313 related articles for article (PubMed ID: 31815738)
1. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression.
Wiedeman AE; Muir VS; Rosasco MG; DeBerg HA; Presnell S; Haas B; Dufort MJ; Speake C; Greenbaum CJ; Serti E; Nepom GT; Blahnik G; Kus AM; James EA; Linsley PS; Long SA
J Clin Invest; 2020 Jan; 130(1):480-490. PubMed ID: 31815738
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.
Coppieters KT; Dotta F; Amirian N; Campbell PD; Kay TW; Atkinson MA; Roep BO; von Herrath MG
J Exp Med; 2012 Jan; 209(1):51-60. PubMed ID: 22213807
[TBL] [Abstract][Full Text] [Related]
3. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
Sarikonda G; Pettus J; Phatak S; Sachithanantham S; Miller JF; Wesley JD; Cadag E; Chae J; Ganesan L; Mallios R; Edelman S; Peters B; von Herrath M
J Autoimmun; 2014 May; 50():77-82. PubMed ID: 24387802
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.
Velthuis JH; Unger WW; Abreu JR; Duinkerken G; Franken K; Peakman M; Bakker AH; Reker-Hadrup S; Keymeulen B; Drijfhout JW; Schumacher TN; Roep BO
Diabetes; 2010 Jul; 59(7):1721-30. PubMed ID: 20357361
[TBL] [Abstract][Full Text] [Related]
5. Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects.
Diggins KE; Serti E; Muir V; Rosasco M; Lu T; Balmas E; Nepom G; Long SA; Linsley PS
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351781
[TBL] [Abstract][Full Text] [Related]
6. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.
Yeo L; Woodwyk A; Sood S; Lorenc A; Eichmann M; Pujol-Autonell I; Melchiotti R; Skowera A; Fidanis E; Dolton GM; Tungatt K; Sewell AK; Heck S; Saxena A; Beam CA; Peakman M
J Clin Invest; 2018 Aug; 128(8):3460-3474. PubMed ID: 29851415
[TBL] [Abstract][Full Text] [Related]
7. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
8. Enhanced CD4
Dwyer AJ; Ritz JM; Mitchell JS; Martinov T; Alkhatib M; Silva N; Tucker CG; Fife BT
Sci Rep; 2021 Aug; 11(1):17142. PubMed ID: 34433860
[TBL] [Abstract][Full Text] [Related]
9. Circulating β cell-specific CD8
Yeo L; Pujol-Autonell I; Baptista R; Eichmann M; Kronenberg-Versteeg D; Heck S; Dolton G; Sewell AK; Härkönen T; Mikk ML; Toppari J; Veijola R; Knip M; Ilonen J; Peakman M
Clin Exp Immunol; 2020 Mar; 199(3):263-277. PubMed ID: 31660582
[TBL] [Abstract][Full Text] [Related]
10. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
[TBL] [Abstract][Full Text] [Related]
11. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP; Li L; Frelinger JA; Tisch R
J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
13. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
Vincent BG; Young EF; Buntzman AS; Stevens R; Kepler TB; Tisch RM; Frelinger JA; Hess PR
J Immunol; 2010 Apr; 184(8):4196-204. PubMed ID: 20220085
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological characteristics of preproinsulin-specific CD8+ T cells in subjects with juvenile-onset and adult-onset type 1 diabetes: A 1-year follow-up study.
Paul M; Badal D; Jacob N; Dayal D; Kumar R; Bhansali A; Bhadada SK; Sachdeva N
Pediatr Diabetes; 2018 Feb; 19(1):68-79. PubMed ID: 28488272
[TBL] [Abstract][Full Text] [Related]
15. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
[TBL] [Abstract][Full Text] [Related]
16. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
[TBL] [Abstract][Full Text] [Related]
17. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts.
Vizler C; Bercovici N; Heurtier A; Pardigon N; Goude K; Bailly K; Combadière C; Liblau RS
J Immunol; 2000 Dec; 165(11):6314-21. PubMed ID: 11086068
[TBL] [Abstract][Full Text] [Related]
18. Antigen presenting cell-targeted proinsulin expression converts insulin-specific CD8
Reeves PLS; Rudraraju R; Wong FS; Hamilton-Williams EE; Steptoe RJ
Eur J Immunol; 2017 Sep; 47(9):1550-1561. PubMed ID: 28665492
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo.
Zaldumbide A; Alkemade G; Carlotti F; Nikolic T; Abreu JR; Engelse MA; Skowera A; de Koning EJ; Peakman M; Roep BO; Hoeben RC; Wiertz EJ
Mol Ther; 2013 Aug; 21(8):1592-601. PubMed ID: 23689598
[TBL] [Abstract][Full Text] [Related]
20. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
